Koşuyolu Kalp Dergisi

1300-8706

Kartal Koşuyolu Yüksek İhtisas EAH

Reversible Congestive Heart Failure After Percutaneous Closure of a Large PDA in a 34-Year-Old Woman

34 Yaflndaki Kadn Hastada Genifl PDA'nn Perkütan Yolla Kapatlmasyla Konjestif Kalp Yetersizli¤inin Gerilemesi

Kargn

Ramazan

Aung

Soe Moe

Candan

Ozkan

Ozdemir

Nihal

Emiro¤lu

Yunus

02 01 2009

13 2 24 25 01 22 2015

1990

Koşuyolu Kalp Dergisi

Patent ductus arteriosus is a congenital heart disease which can cause chronic volume overload leading to congestive heart failure. A 34-year-old woman with rest dyspnea was found to have patent ductus arteriosus and echocardiogram revealed a markedly dilated left ventricle (8.9 cm) and severely-compromised left ventricle systolic functions (ejection fraction~24%). The patent ductus arteriosus was successfully closed percutaneously with Amplatzer occluder device. The patient was discharged on optimal dosages of ramipril, metoprolol, furosemide, spiranolactone and aspirin. On the follow-up after 18 months, the symptoms were found to have regressed and echocardiographic parameters improved (ejection fraction~55%).

Konjenital bir kalp hastal¤ olan patent duktus arteriyozus (PDA) kronik volüm yüküne ba¤l olarak konjestif kalp yetersizli¤ine neden olabilmektedir. 34 yaflnda istirahatde nefes darl¤ olan bir kadn hastada PDA ile ekokardiyografik olarak ileri derece dilate solventrikül (8.9 cm) ve bozulmufl sol ventrikül sistolik fonksiyonu saptadk (ejeksiyon fraksiyon~24%). Patent duktus arteriyozus Amplatzer tkayc alet ile baflarl bir flekilde kapatld. Hasta optimum doz ramipril, metoprolol, furosemide, spiranolactone ve aspirin tedavisi ile taburcu edildi. 18 aylk takip sonucunda semptomlarda gerileme ve ekokardiyografik parametrelerde düzelme saptand.

Patent duktus arteriyozus; Konjestif kalp yetmezli¤i; perkütan kapama.

Patent ductus arteriosus; Congestive heart failure; percutaneous closure

1. Ussia GP, Massimiliano M, Caruso E, Tamburino AR. Combined endothelin receptor antagonist and transcatheter interventional therapy of patent ductus arteriosus with severe pulmonary hypertension. Int J Cardiol 2007;116:427–29.

2. Hokanson JS, Gimelli G, Bass JL. Percutaneous Closure of a Large PDA in a 35-Year-Old Man with Elevated Pulmonary Vascular Resistance. Cong Heart Dis 2008;3:149–54

3. Yan C, Zhao S, Jiang S, Xu Z, Huang L, Zheng H, et al. Transcatheter closure of patent ductus arteriosus with severe pulmonary arterial hypertension in adults. Heart 2007;93:514–18

4. Cheng V, Kazanagra R, Garcia A, Lenert L, Krishnaswamy P, Gardetto N, et al. A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study. J Am Coll Cardiol 2001;37:386 –91.

5. Dickstein K, Solal AC, Filippatos G, McMurray JJV, Ponikowski P, Poole-Wilson PA, et al. ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008. Eur J Heart Fail. 2008;10:933-89